Proteins Suggest a Path to Reduce Drug Resistance in a Form of Cancer | News Release

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

Related Keywords

Richland ,Oregon ,United States ,American ,Kevin Watanabe Smith ,Sara Gosline ,Joshua Hansen ,Karin Rodland ,Karl Weitz ,Jeff Tyner ,Paul Daisy Soros ,Michael Nestor ,Jason Mcdermott ,Cristina Tognon ,Kanupriya Agarwal ,Sunil Joshi ,Elie Traer ,Paul Piehowski ,James Pino ,Tao Liu ,Brian Druker ,Chelsea Hutchinson ,Marina Gritsenko ,Research Program ,National Heart ,Oregon Health Science University ,National Cancer Institute ,Druker Laboratory ,Department Of Energy Pacific Northwest National Laboratory ,Pacific Northwest Biomedical Innovation Co ,Knight Cancer Institute ,Scholar Foundation ,American Cancer Society ,Alex Lemonade Stand Foundation ,School Of Medicine ,Blood Institute ,Evansmds Foundation ,Cell Reports Medicine ,Pacific Northwest National Laboratory ,Oregon Health ,Knight Cancer ,Annual Reviews ,Camilo Posso ,Jamie Moon ,Chelsea Hutchinson Bunch ,Nicola Long ,Cancer Clinical Proteomics Research ,Daisy Soros Fellowship ,Lemonade Stand ,